Deutsche Bank’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Deutsche Bank’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-500	Closed	-$3K	–	5449
2016 Q2	$3K	Buy	+500	New	+$3.75K	﹤0.01%	5070
2015 Q4	–	Sell	-1,000	Closed	-$5K	–	5518
2015 Q3	$5K	Buy	+1,000	New	+$7.7K	﹤0.01%	5055
2015 Q2	–	Sell	-1,000	Closed	-$8K	–	5576
2015 Q1	$8K	Hold	1,000	–	–	﹤0.01%	4839
2014 Q4	$6K	Sell	1,000 -2,550	-72%	-$15.9K	﹤0.01%	5855
2014 Q3	$19K	Buy	3,550 +2,550	+255%	+$14.9K	﹤0.01%	5224
2014 Q2	$6K	Sell	1,000 -1,950	-66%	-$13.4K	﹤0.01%	5607
2014 Q1	$9K	Buy	2,950 +950	+48%	+$7.4K	﹤0.01%	5071
2013 Q4	$6K	Buy	2,000 +1,011	+102%	+$5.46K	﹤0.01%	5014
2013 Q3	$2K	Hold	989	–	–	﹤0.01%	5358
2013 Q2	$2K	Buy	+989	New	+$17.5K	﹤0.01%	5209

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Deutsche Bank's ARIA Position: Q1 2017 in Review

Deutsche Bank sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 1,225,891 shares — an estimated $15.2M sold.

Deutsche Bank first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $33.2M in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Deutsche Bank reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Deutsche Bank sold 1,225,891 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $15.2M.
Deutsche Bank first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
Deutsche Bank's Ariad Pharmaceuticals Inc position peaked at $33.2M in Q3 2013.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Deutsche Bank's 13F filing for Q1 2017, filed 15 May 2017.